What Is Quality by Design and Why It Matters in South KoreaUntitledDesign Quality in, Not Test It In
Quality by Design (QbD) Training in South Korea is a practical, one-day skills programme that teaches teams to build quality into pharmaceutical and biopharmaceutical products from the design stage rather than testing it in at the end. It is grounded in the ICH Q8(R2) Pharmaceutical Development, Q9 Quality Risk Management, Q10 Pharmaceutical Quality System and Q11 guidelines that the Ministry of Food and Drug Safety and global regulators such as the FDA and EMA now expect in modern development and manufacturing submissions. Over a single focused day you learn to apply the full QbD toolkit: the Quality Target Product Profile, critical quality attributes, risk assessment with Ishikawa diagrams and FMEA, Design of Experiments, the design space, Process Analytical Technology and the control strategy. Every tool is practised on realistic development scenarios so the learning transfers straight to work. The course suits formulation and analytical scientists, process development engineers, quality assurance professionals and regulatory affairs specialists across South Korea's fast-growing biologics, biosimilar and CDMO industry. As Korean manufacturers scale for global markets, QbD fluency has become a practical, in-demand capability rather than a nice-to-have.










